Drug comparisons
Dapagliflozin vs Vildagliptin
Compare Dapagliflozin and Vildagliptin for type 2 diabetes: SGLT2 vs DPP-4 inhibitors. Key differences in efficacy, CV/renal benefits, and side effects.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes choosing between SGLT2 and DPP-4 inhibitors, especially with cardiovascular or renal comorbidities.
Bottom line
Dapagliflozin may be preferred for added heart and kidney benefits, while Vildagliptin suits those needing straightforward glycemic control.
All medication comparisons